RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Medulloblastoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
AI-Assisted Molecular Review Refines SMO Inhibitor Candidacy in SHH Medulloblastoma
Chen Buxbaum et al., NEJM AI (16 October 2026)
https://doi.org/10.1056/aics2600997
- 2.
Occipital interhemispheric transtentorial approach for microsurgical resection of a posterior fossa medulloblastoma: 2-dimensional operative video
Guilherme Henrique Weiler Ceccato et al., Surgical Neurology International (16 October 2026)
https://doi.org/10.25259/sni_955_2026
- 3.
Long-term outcomes of pediatric medulloblastoma before routine molecular classification: a 20-year single-center cohort study.
Ertekin Mehtap et al., Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42886346/
- 4.
Conquering Infant and Young Children Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes.
Amayiri Nisreen et al., Pediatric blood & cancer (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42877971/
- 5.
Can Simple MRI Characteristics Predict Molecular Subgroups in Paediatric Medulloblastoma?
McGregor Nigel et al., Journal of medical imaging and radiation oncology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42881537/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
NCT05230758 · Recruiting · Phase 3 · Donald Mabbott
Ages 7 to 21
https://clinicaltrials.gov/study/NCT05230758
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Medulloblastoma
Medulloblastoma is a rare cancerous brain tumour that starts in the cerebellum, the part of the brain controlling balance and coordination. It is most often diagnosed in children and can spread through the fluid around the brain and spinal cord. Treatment usually combines surgery, chemotherapy and, depending on age, radiotherapy, with long-term follow-up for effects on growth and learning.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Medulloblastoma?
Medulloblastoma is a rare cancerous brain tumour that starts in the cerebellum, the part of the brain controlling balance and coordination. It is most often diagnosed in children and can spread through the fluid around the brain and spinal cord. Treatment usually combines surgery, chemotherapy and, depending on age, radiotherapy, with long-term follow-up for effects on growth and learning.
How many clinical trials are available for Medulloblastoma?
RareWays currently indexes 204 clinical trials for Medulloblastoma, of which 34 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Medulloblastoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Medulloblastoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.